targetscan ÏÂÔØ±¾ÎÄ

ÏÖÔÚµÄTargetScan³ÌÐò¿ÉÒÔÖ÷Òª·ÖÈý²¿·Ö×é³É£º

1.Ö÷Ҫ˼ÏëÊÇ˵ÔÚmultiple alignment file ÉÏѰÕÒ±£ÊصÄseed match ÐòÁпÉÒÔÕÒµ½functional miRNA target. ²Î¿¼ÎÄÏ×£ºConserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets

seed match: reverse complimentary to miRNA Seed region, 2-7nt in miRNA 5' end, TargetScan ÓÃmultiple alignment file×÷Ϊinput, ѰÕÒ±£ÊصÄseed match ÐòÁÐ, Ö÷Òª¿¼ÂÇÈýÖÖseed matchµÄÀàÐÍ£º7mer-1a£¨match seed, ¶øÇÒUTRÉÏÓëmiRNA 1nt matchµÄλÖÃÊÇA£©,7mer-m8£¨match miRNA 2-8nt£©, 8mer(match miRNA 2-8, ¶øÇÒUTRÉÏÓëmiRNA 1nt matchµÄλÖÃÊÇA). 2.ºÜ¶à1.ÕÒµ½µÄtarget²»Ò»¶¨»áÓй¦ÄÜ£¬¶øÇÒÓкܶ಻±£ÊصÄseed matchÇøÓòÕÒµ½ÁËһЩÓй¦ÄܵÄmiRNA target site.TargetScan¸ù¾ÝÕâ¸öÏë·¨£¬Ìá³öseed matchÖÜΧµÄÐòÁлá¶ÔmiRNA targetµÄ¹¦ÄܲúÉúÓ°Ï죬ËùÒÔÒýÈëÁËcontext scoreÕâ¸ö¸ÅÄÖ÷Òª°üÀ¨site type contribution(8mer>7mer-m8>7mer-1a),3'paring contribution (ÓÐÎÄÏ×±¨µÀ³ýÁËÓëmiRNA seed ÇøÓòÅä¶Ô£¬ÓëmiRNA12-16ntµÄÅä¶ÔÒ²ÓпÉÄܶÔmiRNA targetµÄ¹¦ÄܲúÉúÓ°Ïì),local AU contribution(AU rich µÄÇøÓò¸üÓпÉÄÜÓй¦ÄÜ)£¬position contribution(ËûÃÇÈÏΪmiRNA targetµÄλÖÃÐèÒªºÍstop codenÖÁÉÙÓÐ15ntµÄ¾àÀ룬¶øÇÒÓй¦ÄܵÄsite¸üÓпÉÄÜλÓÚUTRµÄÁ½¶Ë¶ø²»ÊÇÖм䣬¿ÉÄÜÊÇÒòΪ½Ï³¤UTRµÄÖмäÇøÓòÓпÉÄÜ»áÐγɽϸ´ÔӵĶþ¼¶½á ¹¹£¬Ó°Ïìtarget site accessibility, ´Ó¶øÓ°ÏìÆä¹¦ÄÜ).¾ßÌåcutoff²Î¿¼£º MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing£¬¿¼ÂÇcontextÒԺ󣬶ÔÓںܶ಻±£ÊصÄseed match region,ͬÑù¿ÉÒÔ¼ÆËãÏàÓ¦µÄcontext score, ¶Ô±£ÊغͲ»±£ÊصÄλµã·Ö±ð½øÐÐcontextµÄÅÅÐò£¬ÅÅÃû¿¿Ç°µÄ(±ÈÈçcontext score percentile > 90)ÊÇËûÃÇÈÏΪ±È½ÏÓпÉÄܾßÓй¦ÄܵÄmiRNA°Ðµã

3.PctÖµµÄÒýÈ룬²Î¿¼ÎÄÏ×£ºMost Mammalian mRNAs Are Conserved Targets of MicroRNAs¡£ Ö÷ÒªÊÇϸ»¯Á˱£ÊØÐ͵ļÆË㣬¶Ô²»Í¬µÄ UTR·Ö±ð¼ÆËãÆä±£ÊØÐÔundefined, content, loaded, function, multiple

miRNAÔ¤²âÔ­ÔòºÍÈí¼þ½éÉÜ

ͨ¹ýʵÑé·½·¨È·¶¨miRNAsµÄ×÷Óðбê·Ç³£ºÄʱ£¬ÉÐÎÞ¸ßͨÁ¿µÄ°Ð±ê¼ø¶¨·½·¨¡£Òò´Ë£¬ËäÈ»°Ð»ùÒò¼ø¶¨´æÔÚÉÏÊö¶àÖÖÀ§ÄÑ£¬Í¨¹ýÀíÂÛ·½·¨Ô¤²âmiRNAsµÄ×÷ÓðбêÒÀ¾ÉÊǵ±Ç°É¸Ñ¡ºÍʶ±ðmiRNAs°Ð±êµÄ½ÏΪÀíÏëµÄ;¾¶¡£Ò»°ãÇé¿öÏ£¬ÓÃÓÚmiRNA°Ð»ùÒòÔ¤²âµÄÈí¼þ×ñÑ­Èçϼ¸¸öÔ­Àí£º1 ÐòÁл¥²¹ÐÔ£ºÎ»ÓÚmiRNA 5¡¯¶ËËùνÖÖ×ÓÐòÁÐ(µÚ2-7nt)Óë°Ð»ùÒò3¡¯UTR¿ÉÐγÉWatson-CrickÅä¶ÔÊÇËùÓÐmiRNA°Ð»ùÒòÔ¤²âµÄ×îÖØÒªÒòËØ¡£Åä¶Ô°üÀ¨Èçϼ¸ÖÖÐÎʽ£º¶àÊýÇé¿öÏÂΪ7ntÆ¥Å䣺µÚ2-7ntÓë°Ð»ùÒò³Ê»¥²¹Åä¶Ô£¬Íâ¼ÓÔڰлùÒò¶ÔÓ¦miRNAµÚһλºËÜÕËᴦΪA(7mer-1A site)£¬»òÊÇmiRNAµÚ2-8ntÓë°Ð»ùÒòÍêÈ«Åä¶Ô(7mer-m8 site)£»¶ø¶ÔÓÚmiRNAµÚ2-8ntÓë°Ð»ùÒòÍêÈ«Åä¶Ô£¬ÇÒÍâ¼Ó°Ð»ùÒò¶ÔÓ¦miRNAµÚһλºËÜÕËᴦΪA(8mer site)ÕâÖÖÀàÐÍ£¬ÆäÌØÒìÐÔ¸ü¸ß£»¶ÔÓÚ½ömiRNAµÚ2-7ºËÜÕËáÓë°Ð»ùÒòÍêÈ«Åä¶Ô(6mer site)ÕâÖÖ·½Ê½£¬ÆäÓÃÓÚËÑË÷°Ð»ùÒòµÄÃô¸ÐÐÔ¸ü¸ß£¬ÌØÒìÐÔÏàӦϽµ¡£ÁíÍ⣬»¹ÓÐÖÖ×ÓÐòÁÐÍâµÄ3¡¯ supplementary siteºÍ3¡¯ complementary siteÁ½ÖÖÐÎʽ¡£2 ÐòÁб£ÊØÐÔ¼°ÆäËüÒòËØ£º³ýÁËÐòÁл¥²¹ÐÔÍ⣬°Ð»ùÒòÔ¤²â½Ï¹Ø×¢µÄ»¹°üÀ¨ÐòÁб£ÊØÐÔ¡¢Èȶ¯Á¦Ñ§ÒòËØ¡¢Î»µãµÄ¿É½áºÏÐÔ(accessibility)ºÍUTR¼î»ù·Ö²¼µÈ¶à¸öÒòËØ¡£ÐòÁб£ÊØÐÔ£ºmiRNA½áºÏλµãÔÚ¶à¸öÎïÖÖÖ®¼äÈç¹û¾ßÓб£ÊØÐÔ£¬Ôò¸Ãλµã¸ü¿ÉÄÜΪmiRNAµÄ°Ðλµã¡£Èȶ¯Á¦Ñ§ÒòËØ£ºmiRNA:target¶ÔÐγɵÄ×ÔÓÉÄÜ£¬×ÔÓÉÄÜÔ½µÍ£¬Æä¿ÉÄÜÐÔÔ½´ó¡£Î»µãµÄ¿É½áºÏÐÔ(accessibility)£ºmRNAµÄ¶þ¼¶½á¹¹Ó°ÏìÓëmiRNAµÄ½áºÏÐγÉË«Á´½á¹¹µÄÄÜÁ¦¡£UTR¼î»ù·Ö²¼£ºmiRNA½áºÏλµãÔÚUTRÇøµÄλÖúÍÏàӦλÖõļî»ù·Ö²¼Í¬ÑùÓ°ÏìmiRNAÓë°Ð»ùÒòλµãµÄ½áºÏºÍRISCµÄЧÂÊ¡£ÁíÍ⣬ÖîÈçmiRNAµÄ·Ö²¼Óë°Ð»ùÒò×é

Ö¯·Ö²¼µÄÏà¹ØÐÔÒ²ÊÇÔÚ×ö°Ð»ùÒòÔ¤²âʱҪ¿¼ÂǵÄÖØÒªÒòËØ¡£ÓÃÓÚmiRNA°Ð»ùÒòÔ¤²âµÄÈí¼þÖÖÀàºÜ¶à£¬°üÀ¨miRanda, EMBL, PicTar, TargetScan(S), DIANA-microT 3.0, PITA, ElMMo, rna22, GenMiR++, TarBase, miRBase, miRGen-TargetsµÈ¡£ËäÈ»ÏÖÓеļ¸ÖÖÔ¤²â³ÌÐòÔÚ¼¼Êõϸ½ÚÉÏÓÐËù²»Í¬£¬µ«ËüÃÇÔ¤²âµÄ»ù±¾Ô­ÀíÏàËÆ£¬¶¼ÊÇ»ùÓÚmiRNAsÓë°Ð±êµÄ½áºÏ»úÖÆ¡£2003Ä꣬StarkºÍͬÊÂͨ¹ý³ÌÐò¶ÔºÚ¸¹¹ûӬȫ»ùÒò×éËÑѰ¼ø¶¨Ç±ÔÚµÄmiRNA°Ð±êÊ×Ïȵõ½³É¹¦¡£ÒòΪºÚ¸¹¹ûӬȫ»ùÒò×éÐòÁÐÌṩÁ˷ḻ¶øÇÒ¾«È·µÄ3 ¡¯UTRsµÄÐÅÏ¢¡£°Ñ¹ûÓ¬µÄ3¡¯ UTRsÓëÄâÄϽ桢¹ûÓ¬ºÍ¸Ô±ÈÑǰ´ÎõÄ3¡¯ UTRs±È¶ÔÕÒ³ö±£ÊØ3¡¯ UTRsµÄÐòÁÐ×é³ÉÒ»¸ö±£ÊصÄ3¡¯ UTRsÊý¾Ý¿â£¬È»ºóÓÃHMMer±È¶ÔËÑѰ¹¤¾ßËÑѰ¸ÃÊý¾Ý¿âÓëÒÑÖªmiRNAµÚ2-8¸öºËÜÕËáÍêÈ«»¥²¹Åä¶ÔµÄ3¡¯ UTRsÐòÁУ¬ÔÙÓÃmfoldÈí¼þÅжÏmiRNA°Ð±ê¸´ºÏÌåµÄÈÈÁ¦Ñ§Îȶ¨ÐÔ¡£´Ë·½·¨Ô¤²â³ö¹ûÓ¬Ðí¶àδ֪µÄ°Ð±ê£¬ÆäÖÐÓÐ6¸ö°Ð±êµÃµ½ÊµÑéÑéÖ¤¡£EnrightµÈ½¨Á¢µÄmiRanda·¨Êǵڶþ¸ö¹«²¼µÄmiRNAs°Ð±êÔ¤²â·¨¡£Æä±à³ÌÔ­ÀíÒÀ¾ÝÖ÷ÒªÊÇ£ºÍ¨¹ýµÃ·Ö¾ØÕó¼ÆËã³ö»¥²¹³Ì¶È´óС£¬Ñ°ÕÒ»¥²¹ÐÔ×î¸ßµÄ3¡¯ UTRs£»ÀûÓÃvien-naRNA¼ÆËãmiRNAsºÍ°Ð±ê¸´ºÏÌåÈÈÁ¦Ñ§Îȶ¨ÐÔ£¬²¢ÌÔÌ­²»ÄÜÐγÉË«Á¬ÌåµÄ¼ÙÑôÐ԰бꡣTargetScanΪÁËÔÚÔ¤²âµÄ¿ªÊ¼¹ý³ÌÅųý¼ÙÑôÐÔ£¬Ê×ÏÈÒªÇóseedÑϸñÅä¶Ô£¬ÑÓÉìÐòÁÐÖ±µ½²»Åä¶ÔµÄÇøÓò£¬È»ºó¸ù¾Ý±£ÊØÐÔÔ­Ôò£¬ÌÔÌ­²»¾ßÓÐ3¡¯ UTRs±£ÊØÐòÁеķÖ×Ó£¬×îºóÔËÓÃRNAFold½øÐÐÈÈÁ¦Ñ§Îȶ¨ÐÔɸѡ¡£¸ù¾ÝmiRNA-°Ð±ê¸´ºÏÌåÈÈÁ¦Ñ§Îȶ¨ÐÔÕâÒ»ÌØÐÔ½¨Á¢µÄÔ¤²â·¨ÓÐPicTar¡¢RNAHybridµÈ¡£